icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
Evaluation of Pharmacokinetic Drug-Drug Interaction (DDI) Between BMS-791325, an NS5B Non-Nucleoside Polymerase Inhibitor, Daclatasvir and Asunaprevir in Triple Combination in HCV Genotype 1-Infected Patients
 
 
  Reported by Jules Levin
EASL Amsterdam April 25, 2013
 
Wang X, Li W, Huang S-P, He B, Chung E, Griffies A, Cooney E, Hughes EA, Kandoussi H, Sims K, Gardiner D, Bertz RJ, Eley T Bristol-Myers Squibb, Princeton, NJ, USA

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif